These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 31297871

  • 1. Genome-wide identification of lncRNAs as novel prognosis biomarkers of glioma.
    Song L, Zhang S, Duan C, Ma S, Hussain S, Wei L, Chu M.
    J Cell Biochem; 2019 Dec; 120(12):19518-19528. PubMed ID: 31297871
    [Abstract] [Full Text] [Related]

  • 2. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A, Wang X, Pei Y, Nuermaimaiti N, Tuersunniyazi A, Abula Y, Feng Z, Jiang L, Shi X, Kasimu M.
    Aging (Albany NY); 2021 Jun 03; 13(11):15164-15192. PubMed ID: 34081618
    [Abstract] [Full Text] [Related]

  • 3. Long noncoding RNA RP11-626G11.3 promotes the progression of glioma through miR-375-SP1 axis.
    Zhang Y, Mou C, Shang M, Jiang M, Xu C.
    Mol Carcinog; 2020 May 03; 59(5):492-502. PubMed ID: 32128886
    [Abstract] [Full Text] [Related]

  • 4. Long non-coding RNAs in glioma progression.
    Xi J, Sun Q, Ma L, Kang J.
    Cancer Lett; 2018 Apr 10; 419():203-209. PubMed ID: 29355660
    [Abstract] [Full Text] [Related]

  • 5. Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma.
    Li M, Long S, Hu J, Wang Z, Geng C, Ou S.
    Aging (Albany NY); 2019 Nov 06; 11(21):9405-9423. PubMed ID: 31692451
    [Abstract] [Full Text] [Related]

  • 6. An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients.
    Xia P, Li Q, Wu G, Huang Y.
    Cell Mol Neurobiol; 2021 Mar 06; 41(2):365-375. PubMed ID: 32410107
    [Abstract] [Full Text] [Related]

  • 7. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
    Fan Q, Liu B.
    Med Sci Monit; 2016 Dec 28; 22():5163-5172. PubMed ID: 28028307
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.
    Liu T, Sui J, Zhang Y, Zhang XM, Wu WJ, Yang S, Xu SY, Hong WW, Peng H, Yin LH, Pu YP, Liang GY.
    Oncol Rep; 2018 Sep 28; 40(3):1503-1514. PubMed ID: 30015930
    [Abstract] [Full Text] [Related]

  • 9. Risk assessment model constructed by differentially expressed lncRNAs for the prognosis of glioma.
    Hu C, Zhou Y, Liu C, Kang Y.
    Oncol Rep; 2018 Nov 28; 40(5):2467-2476. PubMed ID: 30106138
    [Abstract] [Full Text] [Related]

  • 10. Prospective Series of Nine Long Noncoding RNAs Associated with Survival of Patients with Glioblastoma.
    Lei B, Yu L, Jung TA, Deng Y, Xiang W, Liu Y, Qi S.
    J Neurol Surg A Cent Eur Neurosurg; 2018 Nov 28; 79(6):471-478. PubMed ID: 29959764
    [Abstract] [Full Text] [Related]

  • 11. Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data.
    Zhang X, Zhang W, Jiang Y, Liu K, Ran L, Song F.
    J Cell Biochem; 2019 Oct 28; 120(10):17898-17911. PubMed ID: 31135068
    [Abstract] [Full Text] [Related]

  • 12. The binding of lncRNA RP11-732M18.3 with 14-3-3 β/α accelerates p21 degradation and promotes glioma growth.
    Kang CM, Bai HL, Li XH, Huang RY, Zhao JJ, Dai XY, Zheng L, Qiu YR, Hu YW, Wang Q.
    EBioMedicine; 2019 Jul 28; 45():58-69. PubMed ID: 31202814
    [Abstract] [Full Text] [Related]

  • 13. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
    Wang XW, Guo QQ, Wei Y, Ren KM, Zheng FS, Tang J, Zhang HY, Zhao JG.
    Oncol Rep; 2019 Dec 28; 42(6):2402-2415. PubMed ID: 31638248
    [Abstract] [Full Text] [Related]

  • 14. Four long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
    Wang J, Pu J, Yao T, Lu X, Deng Y.
    J Cell Physiol; 2019 Jun 28; 234(6):8709-8716. PubMed ID: 30417366
    [Abstract] [Full Text] [Related]

  • 15. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
    Zeng JH, Lu W, Liang L, Chen G, Lan HH, Liang XY, Zhu X.
    J Transl Med; 2019 Aug 23; 17(1):281. PubMed ID: 31443717
    [Abstract] [Full Text] [Related]

  • 16. Survival analysis of immune-related lncRNA in low-grade glioma.
    Li X, Meng Y.
    BMC Cancer; 2019 Aug 16; 19(1):813. PubMed ID: 31419958
    [Abstract] [Full Text] [Related]

  • 17. Long Noncoding RNA ASB16-AS1 Promotes Proliferation, Migration, and Invasion in Glioma Cells.
    Zhang D, Zhou H, Liu J, Mao J.
    Biomed Res Int; 2019 Aug 16; 2019():5437531. PubMed ID: 30949502
    [Abstract] [Full Text] [Related]

  • 18. Identification of key lncRNAs in the carcinogenesis and progression of colon adenocarcinoma by co-expression network analysis.
    Jiang S, Tan B, Zhang X.
    J Cell Biochem; 2019 Apr 16; 120(4):6490-6501. PubMed ID: 30430631
    [Abstract] [Full Text] [Related]

  • 19. Identification and potential mechanisms of a 4-lncRNA signature that predicts prognosis in patients with laryngeal cancer.
    Zhang G, Fan E, Zhong Q, Feng G, Shuai Y, Wu M, Chen Q, Gou X.
    Hum Genomics; 2019 Aug 15; 13(1):36. PubMed ID: 31416476
    [Abstract] [Full Text] [Related]

  • 20. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q, Fan C.
    BMC Med Genet; 2019 Jun 10; 20(1):103. PubMed ID: 31182053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.